QuantuMDx

News and articles related to QuantuMDx – Changing healthcare, Globally

QuantuMDx receives grant funding for TB diagnostic

QuantuMDx receives grant funding for TB diagnostic

Newcastle upon Tyne, UK. QuantuMDx announced today that it received funding from the Bill & Melinda Gates Foundation to further develop and test its CAPTURE-XT™ pathogen concentration technology and Q-POC™ molecular diagnostic (MDx) platform for rapid low cost TB detection and drug susceptibility testing (DST) in response to World Health Organisation target product profiles. The(…)

More

Ministerial visit reinforces QuantuMDx as leaders in innovation in Life Sciences

Ministerial visit reinforces QuantuMDx as leaders in innovation in Life Sciences

The UK’s Minister for Life Sciences, George Freeman MP, today officially opened QuantuMDx’s new HQ and laboratory complex in Newcastle upon Tyne’s Quayside area. Celebrating the first commercial laboratory to be opened in Newcastle’s city centre for many years CEO Elaine Warburton commented “I’m delighted to welcome the minister to our new HQ at The(…)

More

QuantuMDx’s Jonathan O’Halloran Honoured as European CTO of the Year

QuantuMDx’s Jonathan O’Halloran Honoured as European CTO of the Year

QuantuMDx announced today that co-founder Jonathan O’Halloran has been awarded the European Chief Technology Officer (CTO) of the Year 2015 in the SME category. Presented by EIRMA and Spinverse, it is the leading European award honouring excellence in technology and innovation in Europe. The jury is comprised of industry experts including former CTO of Nokia(…)

More

QuantuMDx Group signs new HQ lease with Lugano Property Group

QuantuMDx Group signs new HQ lease with Lugano Property Group

UK based medical technology developer QuantuMDx has signed a long-term lease with Lugano Property Group to move into a 20,000 square foot bespoke head office, situated in the cosmopolitan and vibrant Quayside area of Newcastle upon Tyne. Initial plans are to rationalise QuantuMDx’s operations by creating nine ISO accredited laboratories alongside office space, with an(…)

More

NorthGene CMO Prof Sir John Burn Appointed to NHS Board of Directors

QuantuMDx is delighted to announce that Chief Medical Officer Prof Sir John Burn has been appointed as a non-executive director of NHS England. Sir John is a senior clinical geneticist and academic based in Newcastle upon Tyne, with a passion and vision for bringing innovative technologies into mainstream use. Sir John’s position as non-executive director(…)

More